This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Morning Briefing: 10 Things You Should Know

NEW YORK ( TheStreet) -- U.S. stock futures were suggesting a flat open for Wall Street on Thursday as U.S. lawmakers trying to reach an agreement on how to avert the so-called fiscal cliff appeared at an impasse.

European shares were lower while Asian stocks ended Thursday's session mixed. Japan's Nikkei 225 index fell 1.2% to close at 10,039.33.

The White House on Wednesday threatened to veto House Speaker John Boehner's alternative tax plan as the Jan. 1 fiscal-cliff deadline nears. Boehner has said Republicans in the House may vote Thursday on his "Plan B" bill.


The economic calendar in the U.S. Thursday includes the third and final estimate gross domestic product estimate from the Commerce Department at 8.30 a.m. EST, and the Labor Department's weekly jobless claims report, also at 8:30 a.m.


U.S. stocks on Wednesday fell for the first time this week as politicians wrangled over the "fiscal cliff" deal in Washington.

The Dow Jones Industrial Average declined 99 points, or 0.74%, to 13,252 on Wednesday.


NYSE Euronext (NYX), the operator of the New York Stock Exchange, is in talks to sell itself to rival IntercontinentalExchange (ICE), according to reports.

People close to the discussions told The Wall Street Journal an announcement could come as early as Thursday.

Under a deal, ICE would value NYSE at $33 a share, a 37% premium to its closing price on Wednesday, according to a report from CNBC.


Research In Motion (RIMM), the BlackBerry maker, is expected by analysts on Thursday to post a fiscal third-quarter loss of 35 cents a share.

RIM, which has steadily been losing market share in the U.S., is banking on reversing its fortunes with BlackBerry 10, the new operating system that will be unveiled at the end of next month.


Earnings are also being reported Thursday from the likes of ConAgra Foods (CAG), Nike (NKE) and Discover Financial Services (DFS).


An experimental therapy from Amicus Therapeutics (FOLD) and GlaxoSmithKline (GSK) failed to improve kidney response in Fabry disease patients compared to placebo in a late-stage study, the companies disclosed late Wednesday.


Bed Bath & Beyond (BBBY) on Wednesday issued forecasts for the fourth quarter and fiscal year that were below analysts' views.


Stephen Gillett, president of Best Buy's (BBY) digital business, is joining Symantec (SYMC) as chief operating officer.

-- Written by Joseph Woelfel



>To contact the writer of this article, click here: Joseph Woelfel

>To submit a news tip, send an email to: tips@thestreet.com.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,031.14 +43.63 0.26%
S&P 500 1,984.13 -1.41 -0.07%
NASDAQ 4,518.9020 -48.6960 -1.07%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs